Market research
MVF.AU Monash IVF Group Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 290M
- P/E ratio
- 37.25
- Analyst target
- 0.8054
- Dividend yield
- 3.3%
- Beta
- 0.34
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- AU000000MVF3
- Market cap
- 290M
- P/E ratio
- 37.25
- Analyst target
- 0.8054
- Dividend yield
- 3.3%
- Beta
- 0.34
About
About Monash IVF Group Limited
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MVF.AU discussion.
5 years, 6 months ago
Monash IVF Group Limited is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Monash IVF Group Limited's total revenue rose by 17.8% to $91M since the same quarter in the previous year.
Its net income has increased by 78.5% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 335.7% to $7M since the same quarter in the previous year.
Based on the above factors, Monash IVF Group Limited gets an overall score of 5/5.